NYSE: IXOrix Corp Stock
$38.28-0.20 (-0.52%)
Updated Jun 26, 2026
IX Price
$38.28
Fair Value Price
N/A
Market Cap
$43.03B
52 Week Low
$22.10
52 Week High
$40.63
P/E
15.3x
P/B
1.54x
P/S
1.6x
PEG
1.76x
Dividend Yield
N/A
Revenue
$20.82B
Earnings
$2.80B
Gross Margin
44.2%
Operating Margin
26.25%
Profit Margin
13.4%
Debt to Equity
2.99
Operating Cash Flow
$9B
Beta
0.75
Next Earnings
Aug 6, 2026
Ex-Dividend
N/A
Next Dividend
N/A
IX Overview
ORIX Corporation, a Japanese financial services company, offers leasing, lending, rentals, life insurance, real estate financing and development, venture capital, investment, retail banking, commodities funds, and securities brokering services. ORIX also offers financial services in North America, Asia, the Middle East, and Northern Africa. ORIX was established on 1964 and is headquartered in Tokyo, Japan.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine IX's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Credit Service
Industry Rating
C
IX
Ranked#12 of 46
Ranked#12 of 46
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $41.04 | A | |
| $20.38 | A | |
| $212.45 | B |
Be the first to know about important IX news, forecast changes, insider trades & much more!
IX News
Overview
Due Diligence Score
–
Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IX ($38.28) is trading above its intrinsic value of $20.73, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IX is poor value based on its earnings relative to its share price (15.3x), compared to the US market average (12.38x)
P/E vs Market Valuation
IX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more IX due diligence checks available for Premium users.
Valuation
IX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
15.3x
Industry
28.28x
Market
12.38x
IX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
IX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.54x
Industry
4.75x
IX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
IX price to earnings growth (PEG)
For valuing profitable companies with growth potential
IX is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
IX's financial health
Profit margin
Revenue
$5.8B
Net Income
$360.6M
Profit Margin
6.2%
IX's Earnings (EBIT) of $5.46B... subscribe to Premium to read more.
Interest Coverage Financials
IX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$112.7B
Liabilities
$83.8B
Debt to equity
2.99
IX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
IX's operating cash flow ($8.56B)... subscribe to Premium to read more.
Debt Coverage Financials
IX vs Credit Service Stocks
Orix Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.